EMT tumorigenesis in the mouse mammary gland

Laboratory Investigation

Volumn 87, Issue 12, 2007, Pages 1218-1226

  Damonte, Patrizia ^a   Gregg, Jeffrey P ^b   Borowsky, Alexander D ^a,b   Keister, Blaine A ^c   Cardiff, Robert D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Epithelial mesenchymal transition; Immunohistochemistry; Mice

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CLASSIFICATION; CARCINOGENESIS; CARCINOSARCOMA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FEMALE; GENETIC ENGINEERING; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MESENCHYME CELL; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SARCOMA; SPINDLE CELL; SPINDLE CELL CARCINOMA; STAINING; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MESODERM; MICE; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 36248932120     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700683     Document Type: Article

References (33)

1. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 2005;65:5991-5995; discussion 5995.
2. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65:5996-6000; discussion 6000-5991.
3. Cardiff RD. Epithelial to mesenchymal transition tumors: fallacious or snail's pace? Clin Cancer Res 2005;11(Part 1):8534-8537.
4. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-746.
5. Chaffer CL, Brennan JP, Slavin JL, et al. Mesenchymal-to- epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 2006;66:11271-11278.
6. Gotzmann J, Mikula M, Eger A, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004;566:9-20.
7. Apolant H. Die epithelialen Geschwülste der Maus. Arbeiten ad Koniglchn Inst FExptTher zu Frankfurt aM 1906;1:7-68.
8. Woglom WH. The Study of Experimental Cancer Research. A Review. Columbia University Press: New York, 1913.
9. Haaland M. Spontaneous Tumours in Mice. Imperial Cancer Research Fund: London, 1911, Report No.: 4.
10. Dunn TB. Morphology and histogenesis of mammary tumors. In: Moulton FRe (ed). Symposium on Mammary Tumors in Mice. Am.Assoc.Adv.Sci: Washington, DC, 1945, pp 13-38.
11. Boyer B, Tucker GC, Valles AM, et al. Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. Int J Cancer Suppl 1989;4:69-75.
12. Strizzi L, Bianco C, Normanno N, et al. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J Cell Physiol 2004;201:266-276.
13. White DE, Cardiff RD, Dedhar S, et al. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 2001;20:7064-7072.
14. Moody SE, Perez D, Pan TC, et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005;8:197-209.
15. Landesman-Bollag E, Romieu-Mourez R, Song DH, et al. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 2001;20:3247-3257.
16. Yauch RL, Januario T, Eberhard DA, et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 2005;11(Part 1):8686-8698.
17. Jessen KA, Liu SY, Tepper CG, et al. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res 2004;6:R157-R169.
18. Weiss RS, Matsuoka S, Elledge SJ, et al. Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway. Curr Biol 2002;12:73-77.
19. Gunther EJ, Moody SE, Belka GK, et al. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev 2003;17:488-501.
20. Farago M, Dominguez I, Landesman-Bollag E, et al. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res 2005;65:5792-5801.
21. Sternlicht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 2000;19:1102-1113.
22. Cardiff RD, Leder A, Kuo A, et al. Multiple tumor types appear in a transgenic mouse with the ras oncogene. Am J Pathol 1993;142:1199-1207.
23. Maglione JE, McGoldrick ET, Young LJ, et al. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther 2004;3:941-953.
24. Namba R, Maglione JE, Young LJ, et al. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Mol Cancer Res 2004;2:453-463.
25. Borowsky AD, Namba R, Young LJ, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis 2005;22:47-59.
26. Rosner A, Miyoshi K, Landesman-Bollag E, et al. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 2002;161:1087-1097.
27. Oft M, Heider KH, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998;8:1243-1252.
28. Siegel PM, Shu W, Cardiff RD, et al. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci USA 2003;100:8430-8435.
29. Bindels S, Mestdagt M, Vandewalle C, et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006;25:4975-4985.
30. Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973-981.
31. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002;21:3241-3246.
32. Gobbi H, Simpson JF, Borowsky A, et al. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer 1999;85:2170-2182.
33. Gobbi H, Simpson JF, Jensen RA, et al. Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Mod Pathol 2003;16:893-901.